Literature DB >> 30693897

Clinicopathological study of malignant melanoma in a regional cancer center.

Sasmita Panda1, Sashibhusan Dash1, Kusumbati Besra1, Sagarika Samantaray1, Pramod Chandra Pathy2, Niranjan Rout1.   

Abstract

BACKGROUND: : Malignant melanoma is a tumor of melanocytic origin. Although uncommon in India as compared with the west, its prevalence is increasing.
OBJECTIVES: To document the pattern of clinicopathological features of malignant melanoma cases attending in a regional cancer center in eastern India.
MATERIAL AND METHODS: The present study was a retrospective study of 182 cases diagnosed histopathologically as malignant melanoma during 2011-2016.
RESULTS: Out of the total cases, 170 (93.4%) were cutaneous and 12 (6.6%) were noncutaneous melanoma. The most common age group was sixth decade with a male predominance. Conventional melanotic melanomas were 176 (96.70%), and only 6 cases (3.30%) were amelanotic melanoma. Among noncutaneous melanomas, 6 were in anorectum, 2 in conjunctiva, and 1 case each in nasal cavity, palate, gingivo-buccal sulcus, and vagina. The acrallentigenous type was the most common variety, and the mixed epithelioid and spindle cell type was the most common histopathological pattern. Clark's level III was the most common level of invasion.
CONCLUSION: The lower extremity is the most common site for melanoma, whereas extracutaneous melanomas are exceedingly rare and aggressive neoplasms. Melanoma can metastasize to regional lymph nodes, however, visceral metastasis to liver can also occur. In the absence of pigment in amelanotic melanoma, immunohistochemical markers such as HMB 45 can be used for definitive diagnosis.

Entities:  

Keywords:  Amelanotic malignant melanoma; HMB45; cutaneous melanoma; oral mucosa; vagina

Mesh:

Year:  2018        PMID: 30693897     DOI: 10.4103/ijc.IJC_612_17

Source DB:  PubMed          Journal:  Indian J Cancer        ISSN: 0019-509X            Impact factor:   1.224


  10 in total

1.  Texture Analysis in Diagnosing Skin Pigmented Lesions in Normal and Polarized Light-A Preliminary Report.

Authors:  Paweł Popecki; Kamil Jurczyszyn; Marcin Ziętek; Marcin Kozakiewicz
Journal:  J Clin Med       Date:  2022-04-29       Impact factor: 4.964

2.  Hypoxic Gene Signature of Primary and Metastatic Melanoma Cell Lines: Focusing on HIF-1β and NDRG-1

Authors:  Mustafa Emre Ercin; Önder Bozdoğan; Tarık Çavuşoğlu; Nazan Bozdoğan; Pınar Atasoy; Mukadder Koçak
Journal:  Balkan Med J       Date:  2019-10-09       Impact factor: 2.021

Review 3.  RAGE Signaling in Melanoma Tumors.

Authors:  Olamide T Olaoba; Sultan Kadasah; Stefan W Vetter; Estelle Leclerc
Journal:  Int J Mol Sci       Date:  2020-11-26       Impact factor: 5.923

4.  A Clinicopathological Study of Skin Tumors from a Tertiary Care Centre in North India.

Authors:  Palvi Goel; Sukhjot Kaur; Avantika Garg; Jaskaran Batra; Bhawna Garg; Neena Sood
Journal:  Indian Dermatol Online J       Date:  2021-01-16

5.  Clinical Spectrum of Cutaneous Malignancies in Central India: A Retrospective Study.

Authors:  Bhagyashree Babanrao Supekar; Suyash Singh Tomar; Vaishali H Wankhade; Ravi Bhushan; Rajesh Pratap Singh; Dharitri Mukund Bhat
Journal:  Indian J Dermatol       Date:  2021 May-Jun       Impact factor: 1.494

6.  Demographics, Pattern of Care, and Outcome Analysis of Malignant Melanomas - Experience From a Tertiary Cancer Centre in India.

Authors:  Jyoti Bajpai; George Abraham; Avanish P Saklani; Anshul Agarwal; Sashanka Das; Ambarish Chatterjee; Akhil Kapoor; Prathyusha Eaga; Pradip Kumar Mondal; Arun Chandrasekharan; Prabhat Ghanshyam Bhargava; Sujay Srinivas; Siddharth Turkar; Bharat Rekhi; Nehal Khanna; Amit Kumar Janu; Munita Bal; Vikas Sureshchand Ostwal; Anant Ramaswamy; Jitender Rohila; Ashwin L Desouza; Amrita Guha; Rajiv Kumar; Nandini Sharrel Menon; Sushmita Rath; Vijay Maruti Patil; Vanita Maria Noronha; Amit Prakashchandra Joshi; Siddhartha Laskar; Venkatesh Rangarajan; Kumar Prabhash; Sudeep Gupta; Shripad Banavali
Journal:  Front Oncol       Date:  2021-09-08       Impact factor: 6.244

7.  Not so 'rare'-an example of malignant melanoma in India: report from a tertiary cancer centre.

Authors:  Bivas Biswas; Gautam Biswas; Sandip Ganguly; Joydeep Ghosh; Somnath Roy; Manas Kumar Roy; Amrit Pipara; Jagriti Karmakar; Navonil Mukherjee; Santam Chakraborty; Deepak Kumar Mishra; Divya Midha; Deepak Dabkara
Journal:  Ecancermedicalscience       Date:  2021-12-16

8.  Influencing Mechanism of Nod-Like Receptor Protein 3 Inflammasome Activation in A375 Cell Activity in Human Cutaneous Malignant Melanoma.

Authors:  Akebaier Sulaiman; Jin Lv; Junwei Fan; Reyila Abuliezi; Qian Zhang; Xuefeng Wan
Journal:  J Immunol Res       Date:  2022-07-15       Impact factor: 4.493

9.  Multimodal therapy with surgery and adjuvant nivolumab for late-onset multiple liver metastases of choroidal malignant melanoma: a case report.

Authors:  Ryuta Muraki; Yoshifumi Morita; Shinya Ida; Ryo Kitajima; Satoru Furuhashi; Ryota Kiuchi; Makoto Takeda; Hirotoshi Kikuchi; Yoshihiro Hiramatsu; Takanori Sakaguchi; Akira Kasuya; Yoshihiro Hotta; Hiroya Takeuchi
Journal:  Surg Case Rep       Date:  2020-07-31

10.  Development of a Four-mRNA Expression-Based Prognostic Signature for Cutaneous Melanoma.

Authors:  Haiya Bai; Youliang Wang; Huimin Liu; Junyang Lu
Journal:  Front Genet       Date:  2021-07-15       Impact factor: 4.599

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.